# PURPLE BIOTECH LTD. — Form D

PURPLE BIOTECH LTD. of REHOVOT, L3, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-08. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2017-08-08
- Form: D
- Accession: 0001213900-17-008317
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Investors: 14
- Date of first sale: 2017-07-11
- Revenue range: Decline to Disclose
- SEC file number: 021-292337

## Issuer

- Name: PURPLE BIOTECH LTD.
- CIK: 0001614744
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: 4 OPPENHEIMER STREET, REHOVOT, L3, 7670104
- Phone: +972-3-933-3121

## Officers, directors & promoters (30)

_Showing 25 of 30 people._

| Name | Role | Location |
| --- | --- | --- |
| Avraham Ben-Tzvi | Executive Officer | Berkeley Heights, NJ |
| Eric Rowinsky | Director | Rehovot, L3 |
| Lior Fhima | Executive Officer | Rehovot, L3 |
| Ido Morpurgo | Executive Officer | Rehovot, L3 |
| Michael Schickler | Executive Officer | Rehovot, L3 |
| Simcha Rock | Director | Rehovot, L3 |
| Simcha Rock | Executive Officer | Rehovot, L3 |
| Suzana Nahum-Zilberberg | Director | Rehovot, L3 |
| Yael Margolin | Director | Rehovot, L3 |
| Isaac Israel | Director | TEL AVIV, L3 |
| Isaac Israel | Executive Officer | TEL AVIV, L3 |
| Hadas Reuveni | Executive Officer | Rehovot, L3 |
| Gil Efron | Executive Officer | Rehovot, L3 |
| Ori Hershkovitz | Director | Rehovot, L3 |
| Ido Agmon | Director | Rehovot, L3 |
| Robert Gagnon | Director | Rehovot, L3 |
| Fabien Sebille | Executive Officer | Rehovot, L3 |
| Ran Tzror | Director | Tel Aviv, L3 |
| Steven Steinberg | Director | Tel Aviv, L3 |
| Revital Stern-Raff | Director | Tel Aviv, L3 |
| Bertrand Liang | Executive Officer | Tel Aviv, L3 |
| Gil Ben-Menachem | Director | Tel Aviv, L3 |
| Gil Ben-Menachem | Executive Officer | Tel Aviv, L3 |
| John Paul Waymack | Director | Tel Aviv, L3 |
| John Paul Waymack | Executive Officer | Tel Aviv, L3 |

## Other filings by this issuer (12)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-07-15](https://search.stillhousedata.com/formd/0001213900-24-061353) | D | $4.5M | $4.5M |
| [2023-10-31](https://search.stillhousedata.com/formd/0001213900-23-081834) | D | $5.4M | $5.4M |
| [2020-07-14](https://search.stillhousedata.com/formd/0001213900-20-017429) | D | — | — |
| [2020-05-15](https://search.stillhousedata.com/formd/0001213900-20-012640) | D | $10.0M | $10.0M |
| [2020-05-04](https://search.stillhousedata.com/formd/0001213900-20-010903) | D | $6.5M | $6.5M |
| [2020-01-21](https://search.stillhousedata.com/formd/0001213900-20-001455) | D | — | — |
| [2019-01-24](https://search.stillhousedata.com/formd/0001213900-19-001171) | D | $6.0M | $6.0M |
| [2018-06-07](https://search.stillhousedata.com/formd/0001213900-18-007376) | D | $8.2M | $8.2M |
| [2018-03-26](https://search.stillhousedata.com/formd/0001213900-18-003403) | D | — | — |
| [2017-11-01](https://search.stillhousedata.com/formd/0001213900-17-011192) | D | — | — |
| [2016-05-02](https://search.stillhousedata.com/formd/0001144204-16-098167) | D | — | — |
| [2016-02-04](https://search.stillhousedata.com/formd/0001144204-16-078901) | D | — | — |

## More

- [CIK 1614744 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1614744&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001213900-17-008317.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.